Acquisition aims to transform testosterone treatment accessibility
Leger Clinic, a provider of testosterone replacement therapy (TRT) originally founded in Doncaster, South Yorkshire, has officially joined the Medichecks Group.
The deal is intended to strengthen South Yorkshire’s legacy as a hub for healthcare innovation.
Leger has been offering testosterone therapy for over 25 years. As part of the Medichecks Group, it will streamline access to testing, treatment, and expert-led care through its online platform.
Blood testing plays a vital role in TRT, ensuring patients receive safe and effective treatment.
With Medichecks’ advanced blood testing services now fully integrated into Leger’s care model, patients will no longer need to source external tests. This should mean faster results, simpler processes, and lower costs.
Medical director, Dr Douglas Savage, founded Leger Clinic in 1987. He said: “Testosterone deficiency is a real issue. Patients tell us they’ve lost their get-up-and-go, they’re miserable, and their partners are noticing it too.
“I’ve seen first-hand how TRT can transform men’s lives. It’s not just about increasing testosterone – it’s about giving men back their energy, confidence, and drive.
“By joining Medichecks, we can make monitoring simpler, more affordable, and ensure men get the care they need without unnecessary barriers.”
Helen Marsden, co-founder of Medichecks, added: “At Medichecks, we’re committed to making healthcare simple and accessible.
“Acquiring Leger means we’re ensuring that more men can benefit from expert TRT treatment backed by seamless, high-quality monitoring. We want men to take control of their health and feel their best again.”
